Search research articles
Contact Us
Filters
Showing results (71-80 of 123) with videos related to
Page
of 13
Sort By:
Oncology
|
November 7, 2013
Management of 'in-field' skin toxicity in head and neck cancer patients treated with combined cetuximab and radiotherapy
Domenico Cante, Maria Rosa La Porta, Pierfrancesco Franco, et al.
Anticancer Research
|
March 25, 2010
EGFR status and prognosis of patients with locally advanced head and neck cancer treated with chemoradiotherapy
Gianmauro Numico, Elvio Grazioso Russi, Ida Colantonio, et al.
Anticancer Research
|
August 6, 2005
Carboplatin and weekly paclitaxel in non-small cell lung cancer patients unfit for or pretreated with chemotherapy
Gianmauro Numico, Ida Colantonio, Milena Gasco, et al.
Cancer
|
January 25, 2005
Prospective evaluation of major vascular events in patients with nonsmall cell lung carcinoma treated with cisplatin and gemcitabine
Gianmauro Numico, Ornella Garrone, Vincenzo Dongiovanni, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 1, 2006
Prospective multicenter study of combined treatment with chemotherapy and radiotherapy in breast cancer women with the rare clinical scenario of ipsilateral supraclavicular node recurrence without distant metastases
Stefano Pergolizzi, Vincenzo Adamo, Elvio Russi, et al.
JCO Oncology Practice
|
February 13, 2020
Comment on Medication-Related Osteonecrosis of the Jaw: MASCC/ISOO/ASCO Clinical Practice Guideline Summary
Vittorio Fusco, Daniele Santini, Giuseppina Campisi, et al.
Acta Oncologica (Stockholm, Sweden)
|
March 21, 2006
Paclitaxel, cisplatin and 5-fluorouracil in recurrent squamous cell carcinoma of the head and neck: a phase II trial from an Italian cooperative group
Marco Benasso, Anna Ponzanelli, Marco Merlano, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
August 10, 2005
Paclitaxel, cisplatin, 5-fluorouracil and radiotherapy in the management of advanced squamous cell carcinoma of the head and neck: a phase II trial
Marco Merlano, Elvio G Russi, Gianmauro Numico, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology
|
April 15, 2020
Prognostic role of early PSA drop in castration resistant prostate cancer patients treated with abiraterone acetate or enzalutamide
Consuelo Buttigliero, Marcello Tucci, Cristina Sonetto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 16, 2000
Sequence effect of epirubicin and paclitaxel treatment on pharmacokinetics and toxicity
M Venturini, G Lunardi, L Del Mastro, et al.
Page
of 13
Search research articles
Search
Showing results (71-80 of 123) with videos related to
Sort By:
Page
of 13
Oncology
|
November 7, 2013
Management of 'in-field' skin toxicity in head and neck cancer patients treated with combined cetuximab and radiotherapy
Domenico Cante, Maria Rosa La Porta, Pierfrancesco Franco, et al.
Anticancer Research
|
March 25, 2010
EGFR status and prognosis of patients with locally advanced head and neck cancer treated with chemoradiotherapy
Gianmauro Numico, Elvio Grazioso Russi, Ida Colantonio, et al.
Anticancer Research
|
August 6, 2005
Carboplatin and weekly paclitaxel in non-small cell lung cancer patients unfit for or pretreated with chemotherapy
Gianmauro Numico, Ida Colantonio, Milena Gasco, et al.
Cancer
|
January 25, 2005
Prospective evaluation of major vascular events in patients with nonsmall cell lung carcinoma treated with cisplatin and gemcitabine
Gianmauro Numico, Ornella Garrone, Vincenzo Dongiovanni, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 1, 2006
Prospective multicenter study of combined treatment with chemotherapy and radiotherapy in breast cancer women with the rare clinical scenario of ipsilateral supraclavicular node recurrence without distant metastases
Stefano Pergolizzi, Vincenzo Adamo, Elvio Russi, et al.
JCO Oncology Practice
|
February 13, 2020
Comment on Medication-Related Osteonecrosis of the Jaw: MASCC/ISOO/ASCO Clinical Practice Guideline Summary
Vittorio Fusco, Daniele Santini, Giuseppina Campisi, et al.
Acta Oncologica (Stockholm, Sweden)
|
March 21, 2006
Paclitaxel, cisplatin and 5-fluorouracil in recurrent squamous cell carcinoma of the head and neck: a phase II trial from an Italian cooperative group
Marco Benasso, Anna Ponzanelli, Marco Merlano, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
August 10, 2005
Paclitaxel, cisplatin, 5-fluorouracil and radiotherapy in the management of advanced squamous cell carcinoma of the head and neck: a phase II trial
Marco Merlano, Elvio G Russi, Gianmauro Numico, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology
|
April 15, 2020
Prognostic role of early PSA drop in castration resistant prostate cancer patients treated with abiraterone acetate or enzalutamide
Consuelo Buttigliero, Marcello Tucci, Cristina Sonetto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 16, 2000
Sequence effect of epirubicin and paclitaxel treatment on pharmacokinetics and toxicity
M Venturini, G Lunardi, L Del Mastro, et al.
Page
of 13